期刊文献+

Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice 被引量:11

Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice
下载PDF
导出
摘要 AIM: To prepare chitosan-polyaspartic acid-5-fluorouracil (CTS-Pasp-5Fu) nanoparticles and investigate its anti-carcinoma effect and toxicity. METHODS: CTS-Pasp-5Fu nanoparticles were synthesized by ionic gelatification. Male BABL/c nude mice were injected with SGC-7901 gastric carcinoma cell line mass to establish a human gastric carcinoma model. They were randomly allocated into 4 groups: CTS-Pasp-5Fu (containing 5-Fu 1.25 mg/kg), 5-Fu (1.25 mg/kg), CTS-Pasp and normal saline groups. Tumor weight was measured and assay of colony forming unit-granulocyte and macrophage (CFU-GM) was performed. The structural change of cells and tissues was observed and the Bax and Bcl-2 genes were detected. RESULTS: Compared with normal saline, the inhibition rates of tumor growth for the CTS-Pasp, 5-Fu and CTS-Pasp-5Fu groups were 5.58%, 58.69% and 70.82%, respectively. The tumor inhibition rates for the CTS-Pasp, 5-Fu and CTS-Pasp-5Fu groups were 5.09%, 65.3% and 72.79%, respectively. There was a significant decrease in the number of CFU-GMformation and increase of total bilirubin, and alanine aminotransferase in the 5-Fu group, but no change in those of the other three groups. There was no change in white blood cell count and creatinine among the four groups. Pathological section of liver and nephridial tissues showed that the damage in the 5-Fu group was more severe than that in the CTS-Pasp-5Fu group. 5-Fu and CTS-Pasp-5Fu groups could both down-regulate the Bcl-2 expression and up-regulate the Bax expression to different extent, and the accommodate effect of CTS-Pasp-5Fu was more obvious than 5-Fu. CONCLUSION: The tumor inhibition rate of CTS-Pasp-5Fu nanoparticles is much higher than that of 5-Fu alone. AIM: To prepare chitosan-polyaspartic acid-5-fluorouracil (CTS-Pasp-5Fu) nanoparticles and investigate its anti-carcinoma effect and toxicity. METHODS: CTS-Pasp-5Fu nanoparticles were synthesized by ionic gelatification. Male BABL/c nude mice were injected with SGC-7901 gastric carcinoma cell line mass to establish a human gastric carcinoma model. They were randomly allocated into 4 groups: CTS-Pasp-5Fu (containing 5-Fu 1.25 mg/kg), 5-Fu (1.25 mg/kg), CTS-Pasp and normal saline groups. Tumor weight was measured and assay of colony forming unit-granulocyte and macrophage (CFU-GM) was performed. The structural change of cells and tissues was observed and the Bax and Bcl-2 genes were detected. RESULTS: Compared with normal saline, the inhibition rates of tumor growth for the CTS-Pasp, 5-Fu and CTS-Pasp-5Fu groups were 5.58%, 58.69% and 70.82%, respectively. The tumor inhibition rates for the CTS-Pasp, 5-Fu and CTS-Pasp-5Fu groups were 5.09%, 65.3% and 72.79%, respectively. There was a significant decrease in the number of CFU-GM formation and increase of total bilirubin, and alanine aminotransferase in the 5-Fu group, but no change in those of the other three groups. There was no change in white blood cell count and creatinine among the four groups. Pathological section of liver and nephridial tissues showed that the damage in the 5-Fu group was more severe than that in the CTS-Pasp-5Fu group. 5-Fu and CTS-Pasp-5Fu groups could both down-regulate the Bcl-2 expression and up-regulate the Bax expression to different extent, and the accommodate effect of CTS-Pasp-5Fu was more obvious than 5-Fu. CONCLUSION: The tumor inhibition rate of CTS-Pasp-5Fu nanoparticles is much higher than that of 5-Fu alone.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第22期3554-3562,共9页 世界胃肠病学杂志(英文版)
基金 Shanghai Science and Technology Committee, No. 0452nm065
关键词 5-FLUOROURACIL CHITOSAN Polyaspartic acid NANOPARTICLES Gastric carcinoma 胃癌 5-氟尿嘧啶 壳聚糖 抗癌效果
  • 相关文献

参考文献33

  • 1[1]Grem JL.5-Fluorouracil:forty-plus and still ticking.A review of its preclinical and clinical development.Invest New Drugs 2000; 18:299-313 被引量:1
  • 2[2]Llorca Ferrandiz C,Esquerdo Galiana G,Cervera Grau JM,Briceo Garcia HC,Calduch Broseta JV,Del Pino Cuadrado J.[5-Fluorouracil-induced small bowel toxicity in a patient with colorectal cancer] Clin Transl Oncol 2005; 7:356-357 被引量:1
  • 3[3]Saif MW.Capecitabine versus continuous-infusion 5-fluorouracil for colorectal cancer:a retrospective efficacy and safety comparison.Clin Colorectal Cancer 2005; 5:89-100 被引量:1
  • 4[4]Diasio RB,Johnson MR.The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil.Pharmacology 2000; 61:199-203 被引量:1
  • 5[5]Ogawa K,Yui T,Okuyama K.Three D structures of chitosan.Int J Biol Macromol 2004; 34:1-8 被引量:1
  • 6[6]Prabaharan M,Mano JF.Chitosan-based particles as controlled drug delivery systems.Drug Deliv 2005; 12:41-57 被引量:1
  • 7[7]Aspden TJ,Mason JDT,Jones NS.Chitosan as a nasal delivery system:the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers.J Pharm Sci 1997; 86:509-513 被引量:1
  • 8[8]Chornet E,Dumitriu S.Inclusion and release of proteins from polysaccharide-based polyion complexes.Adv Drug Deliv Rev 1998; 31:223-246 被引量:1
  • 9[9]Takeuchi H,Yamamoto H,Niwa T,Hino T,Kawashima Y.Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes.Pharm Res 1996; 13:896-901 被引量:1
  • 10[10]Park SB,You JO,Park HY,Haam SJ,Kim WS.A novel pH-sensitive membrane from chitosan-TEOS IPN; preparation and its drug permeation characteristics.Biomaterials 2001; 22:323-330 被引量:1

同被引文献67

引证文献11

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部